Effect of herbal formulation on glimepiride pharmacokinetics and pharmacodynamics in nicotinamide-streptozotocin-induced diabetic rats

被引:1
作者
Thikekar, Archana K. [1 ]
Thomas, Asha B. [1 ,3 ]
Chitlange, Sohan S. [1 ]
Bhalchim, Vrushali [2 ]
机构
[1] Dr DY Patil Inst Pharmaceut Sci & Res, Dept Pharmaceut Chem, Pune, Maharashtra, India
[2] Dr DY Patil Inst Pharmaceut Sci & Res, Dept Pharmacol, Pune, Maharashtra, India
[3] Dr DY Patil Inst Pharmaceut Sci & Res, Pune 411018, Maharashtra, India
关键词
Diabetes; Glimepiride; Diabecon; HDI; TINOSPORA-CORDIFOLIA; GYMNEMA-SYLVESTRE; DRUG-INTERACTIONS; CYTOCHROMES P450; EXTRACT; INHIBITION; METABOLISM; TOLBUTAMIDE; MELLITUS; CYP2C9;
D O I
10.1016/j.jaim.2022.100633
中图分类号
R [医药、卫生];
学科分类号
10 ;
摘要
Background: Traditional medicinal herbs are widely consumed in developing countries to treat diabetes as they are perceived to be safer, less expensive, and have fewer side effects as compared to the con-ventional medicines. Diabecon (DB), Himalaya Herbal Healthcare, India is herbal over-the-counter formulation which contains several herbs that are reported in the traditional texts for the treatment of diabetes. The majority of these herbs have been investigated and found to interfere with the cyto-chrome pathway. The most common oral antihyperglycemic drug used today in clinical practice is Gli-mepiride (GP).The CYP2C9 enzyme is mainly responsible for the metabolism of GP. Herein we hypothesize that the co-administration of GP with DB may result in possible HerbeDrug Interactions (HDIs) as DB has the potential to significantly inhibit the CYP2C9 enzyme.Objective: In the current study, the pharmacokinetic and pharmacodynamic interactions of GP (0.82 mg/ kg) with DB (110.95 mg/kg) was investigated in diabetes induced (Nicotinamide-STZ) rats by co -administering both drugs orally for 21 days.Materials and methods: For the study of the HDI, Bioanalytical RP-HPLC/PDA method for quantifying GP in plasma of rats was developed and validated as per US-FDA guidelines. In vivo pharmacokinetic and pharmacodynamic parameters were studied on day 1 and day 21 post administration.Results: The RP-HPLC/PDA method was successfully employed for quantification of GP in the PK studies. The co-administration of GP and DB in diabetic rats resulted in beneficial pharmacodynamic interactions, but there were no notable changes in the pharmacokinetic parameters of GP.Conclusion: This current investigation in an animal model suggests that co-administration of GP and DB may have significant therapeutic benefits in the treatment of diabetes; however, additional research, randomized clinical trials or case studies in humans, is needed.(c) 2022 The Authors. Published by Elsevier B.V. on behalf of Institute of Transdisciplinary Health Sciences and Technology and World Ayurveda Foundation. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
引用
收藏
页数:9
相关论文
共 37 条
  • [1] The inhibition of CYP1A2, CYP2C9, and CYP2D6 by pterostilbene in human liver microsomes
    Albassam, A. A.
    Ahad, A.
    Alsultan, A.
    Yusufoglu, H. S.
    Foudah, A., I
    Al-Jenoobi, F., I
    [J]. PHARMAZIE, 2021, 76 (04): : 155 - 158
  • [2] [Anonymous], 2001, AYURVEDIC PHARMACOPO, V2, P127
  • [3] [Anonymous], 2008, AYURVEDIC PHARMACOPO, V6, P32
  • [4] [Anonymous], 2001, AYURVEDIC PHARMACOPO, V5, P128
  • [5] [Anonymous], 2017, SYNERGY, DOI DOI 10.1016/J.SYNRES.2017.11.002
  • [6] [Anonymous], 2001, AYURVEDIC PHARMACOPO, V2, P48
  • [7] [Anonymous], 2001, AYURVEDIC PHARMACOPO, V4, P108
  • [8] [Anonymous], 2001, The Ayurvedic Pharmacopoeia of India, VI
  • [9] Cytochromes P450 and metabolism of xenobiotics
    Anzenbacher, P
    Anzenbacherová, E
    [J]. CELLULAR AND MOLECULAR LIFE SCIENCES, 2001, 58 (5-6) : 737 - 747
  • [10] Inhibition of human recombinant cytochrome P450s by curcumin and curcumin decomposition products
    Appiah-Opong, Regina
    Commandeur, Jan N. M.
    van Vugt-Lussenburg, Barbara
    Vermeulen, Nico P. E.
    [J]. TOXICOLOGY, 2007, 235 (1-2) : 83 - 91